fda deadline semaglutide As of February 21, 2025, the updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Compounded Semaglutide Manufacturing Ban

Rybelsus is the world's first oral GLP-1 receptor agonist

A deeper understanding of the heterogeneous nature of MASLD has recently contributed to the discovery of novel groups of agents and the potential repurposing of currently available medications

announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy (semaglutide) with Novo Nordisk.

Store at 2C to 8C

Learn what to do, the side effects to watch for, and how to stay on track

In our April issue of , Chris Aiken and David Liebers take a hard look at where these drugs really fit ( Highlights: , : GLP-1s can reverse antipsychotic weight gainsomething metformin rarely achieves once weight is established